このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

CADはSTINGをハイジャックし,抗腫瘍免疫と結腸直腸がんの放射線療法の有効性を損なう

  • 0Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

|

|

まとめ

この要約は機械生成です。

カスパース活性化DNase (CAD) は,放射線治療後の抗腫瘍免疫を抑制する. 大腸がんにおける放射性免疫療法とT細胞の反応を高めます.

科学分野

  • 腫瘍学
  • 免疫学
  • 分子生物学

背景

  • 放射線治療 (RT) と免疫治療は,免疫チェックポイントブロック (ICB) のように,重要ながん治療です.
  • cGAS/STING経路は,DNA損傷反応と抗腫瘍免疫を結びつけ,放射線感受性の標的となる.
  • この経路の新規調節物質を特定することは,放射線免疫療法 (RIT) の改善に極めて重要です.

研究 の 目的

  • 結腸直腸がん (CRC) の放射線免疫療法 (RIT) の有効性を高める新しい分子標的を特定する.
  • カスパース活性化DNase (CAD) がcGAS/STINGシグナル伝達経路を調節する役割とその放射線感受性への影響を調査する.

主な方法

  • カスパース活性化DNase (CAD) がcGAS/STINGシグナリングを調節する役割を調査した.
  • 腫瘍の微小環境,CD8+T細胞の浸透,放射線と併合した抗PD-1免疫療法の効果を評価した.
  • 結腸直腸がん (CRC) 患者のサンプルを用いて翻訳的検証を行った.

主要な成果

  • カスパース活性化DNase (CAD) は,その核酵素活性とは独立して,cGAS/ STINGシグナル伝達の抑制剤として特定された.
  • CADはSTINGの二分化と活性化を物理的に阻害し,放射線治療後のI型インターフェロン (IFN- I) の生成を減少させます.
  • 放射線治療と抗PD-1療法と連携して,CD8+ T細胞の浸透と活性化を強化した.
  • CRCにおけるCADの過剰発現は,放射線治療への反応の低下と,腫瘍内CD8+T細胞の浸透の減少と相関する.

結論

  • カスパース活性化DNase (CAD) は,大腸がんにおけるcGAS- STINGシグナル伝達と放射線感受性を制御する新しいレオスタットとして作用する.
  • 放射線治療と放射線免疫療法 (RIT) の有効性を高める可能性のある戦略は,CADの抑制です.
  • CAD調節は,抗腫瘍免疫と結腸直腸がんの治療結果を改善するための有望なアプローチを提供します.

関連する概念動画

Inhibition of Cdk Activity 02:34

4.9K

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Targeted Cancer Therapies 02:57

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies 02:49

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy 01:27

660

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drugs that Destabilize Microtubules 01:10

2.0K

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Drugs that Stabilize Microtubules 01:15

2.1K

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...